市場調査レポート
商品コード
1417590
使い捨て手術器具の世界市場の評価:製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Disposable Surgical Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
使い捨て手術器具の世界市場の評価:製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年01月29日
発行: Market Xcel - Markets and Data
ページ情報: 英文 248 Pages
納期: 3~5営業日
|
世界の使い捨て手術器具の市場規模は、2023年に59億4,000万米ドル、2031年に108億4,000万米ドルに達し、2023年~2031年の予測期間にCAGRで7.8%の成長が見込まれています。世界の使い捨て手術器具市場は急成長市場です。使い捨て手術器具市場は、外科手術の増加、使い捨て手術器具への選好、COVID-19後の認識などの要因によって牽引されています。
交通事故の多発や慢性疾患などの理由により、世界中で外科手術の施術数が増加しているため、より多くの手術器具に対する需要が生じています。外科手術の施術数が年々増加していることから、使い捨て手術器具の売上は大幅に増加しています。シングルユースまたは使い捨ての手術器具は、感染予防と患者の安全性を確保するため、医療提供者だけでなく患者にも好まれており、使い捨て手術器具の需要をさらに高めています。さらに、COVID-19による意識の高まりが、使い捨て手術器具や個人用保護具(PPE)のような備品の需要を増加させています。しかし、使い捨て手術器具による医療廃棄物の増加や、非侵襲性の代替の器具の利用可能性が、世界の使い捨て手術器具市場にマイナスの影響を与える障害となっています。
例えば2023年6月、Omnivision(大手半導体ソリューションプロバイダー)は、脊椎、子宮腎臓、神経、眼科、心臓処置などの広範な用途を持つシングルユース内視鏡向けの新しい超薄型医療グレードケーブルモジュール、OVMed OCHTAを発売しました。2022年11月、Omnivisionは、使い捨ておよび再利用可能な内視鏡向けの正方形200万画素(1,500MP x 1,500MP)解像度のOH02Bイメージセンサーを発売しました。
外科手術は、緊急時や薬物投与が不十分な場合に行われることが多いです。口腔がんや咽頭がんのようながん症例の増加により、がん組織の手術による除去が必要となっています。それとともに、外科手術につながる多数の交通事故や、心血管疾患や消化器疾患などの慢性疾患が、使い捨て手術器具の需要を押し上げています。WHOによると、世界では毎年3億件以上の外科手術が行われています。2023年10月、The Hinduによると、インドの手術件数は人口が約14億人である一方で10万人当たり166~3,646件であり、これは環境、人口などの要因によって異なります。
感染の予防と管理は、患者の安全性とその後の外科手術における医療機器の使用に直結しています。使い捨て手術器具の使用は感染の可能性を排除するため、これらの器具の需要を促進しています。COVID-19後の意識の結果、医療従事者は感染の可能性を避けるために使い捨ての手術器具やPPEを好むようになっています。手術を受ける患者も同じ理由で使い捨て器具を好みます。使い捨て手術器具への選好が高まる中、市場参入企業は新製品の発表に賭けています。例えば、2022年6月、Johnson and Johnson MedTech傘下のEthiconは、手術用次世代ステープラーECHELON 3000を発売しました。ECHELON 3000 45mm 60mm Staplerは、組織の切断とステープルを同時に行う滅菌済みの使い捨て器具です。この器具は、切断、切除、吻合の創出を目的としています。
世界の使い捨て手術器具では、手術器具セグメントが予測期間に優位を占めると予測されます。縫合糸、ステープラー、電気手術器などの手術器具は、ほとんどすべての種類の手術で非常によく使用されています。これらの器具は、手術後の傷口、切り口、切開部を封止して閉じるために使用されます。世界中で手術件数が増加し、院内感染を避けられる使い捨て手術器具への選好が強まっていることが、手術器具セグメントの促進要因となっており、このセグメントの大きな金額シェアを維持しています。
当レポートでは、世界の使い捨て手術器具市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。
Global disposable surgical devices market size was valued at USD 5.94 billion in 2023, and is expected to reach USD 10.84 billion in 2031, with a CAGR of 7.8% for the forecast period between 2023 and 2031F. The global disposable surgical devices market is a fast-growing market. The disposable surgical devices market is driven by factors such as the increasing number of surgical procedures, preference for single-use disposable surgical devices, and post-COVID-19 awareness.
The increasing number of surgical procedures being performed across the globe due to reasons such as high number of road accidents and chronic diseases generate demand for more surgical devices. As more surgical procedures are being performed annually, the sales of disposable surgical devices are increasing significantly. Single-use or disposable surgical devices are preferred by healthcare providers as well as patients to ensure infection prevention and patient safety, further increasing the demand for disposable surgical devices. Additionally, the increasing awareness due to COVID-19 has increased the demand for disposable surgical devices and equipment like personal protective equipment (PPEs). However, growing medical wastage due to disposable surgical devices and the availability of non-invasive and alternative devices are some hindrances that negatively affect the global disposable surgical devices market.
For instance, in June 2023, Omnivision (a leading semiconductor solutions provider) launched the new ultra-thin medical-grade cable module, OVMed OCHTA, for single-use endoscopes which has widespread applications like spinal, utero-renal, neurological, ophthalmic, and cardiac procedures. In November 2022, Omnivision launched a square two-megapixel (1,500MP x 1,500MP) resolution OH02B image sensor for disposable and reusable endoscopes.
Surgical procedures are often used for emergency cases and in cases where medicine administration is insufficient. The growing number of cancer cases like oral cancer, throat cancer, and many others require surgical removal of cancerous tissues. Along with it, the high number of road accidents leading to surgical procedures and chronic diseases, such as cardiovascular diseases and gastrointestinal diseases, are driving the demand for disposable surgical devices. According to WHO, over 300 million surgical procedures are being performed each year, globally. In October 2023, as per The Hindu, the rate of surgeries in India is between 166 and 3,646 surgeries per 100,000 individuals, depending on the setting, population, and other factors while the population is about 1.4 billion.
Infection prevention and control are directly linked to patient safety and the subsequent use of medical equipment for surgical procedures. The use of disposable surgical devices eliminates the chances of infection, which drives the demand for these devices. As a result of post-COVID-19 awareness, healthcare professionals have an increasing preference for disposable surgical devices and PPEs to avoid any chance of infection. Patients undergoing surgeries prefer disposable devices for the same reason. With increasing preference for single-use disposable surgical devices, the market players are betting on new product launches. For instance, in June 2022, Ethicon, part of Johnson and Johnson MedTech, launched a next-generation ECHELON 3000 stapler for surgical use. ECHELON 3000 45mm and 60mm Staplers are sterile, single-patient-use instruments that cut and staple tissues simultaneously. The device is intended for transection, resection, and/or creation of anastomoses.
The surgical instruments segment in global disposable surgical devices is expected to dominate during the forecast period. Surgical instruments like sutures, staplers, and electrosurgical devices are very commonly used in almost all kinds of surgeries. These instruments are used for sealing and closing wounds, cuts, and incisions after surgeries. The growing number of surgeries across the globe and increasing preference for disposable surgical devices to avoid hospital acquired infections is acting as a driver for the surgical instruments segment and maintaining the larger value share for the segment.
With high investment in research and development activities, technological advancements by key players, and highly advanced healthcare infrastructure in countries, like the United States and Canada, the region is expected to dominate the market with the highest value share. Supportive government initiatives for managing the growing number of surgical procedures are embracing the growth of the market in the region. High disposable income and preference for single-use disposable surgical devices for the prevention of infections are contributing to the dominance of North America in the disposable surgical devices market.
The growing emphasis on infection prevention and control by WHO and other regulatory agencies has significantly upsurged the popularity of disposable surgical devices. In May 2022, as per WHO's first-ever global report on infection prevention and control, over 24% of patients are affected by healthcare-associated sepsis, and 52.3% of those patients die every year during their hospital stay. The awareness about healthcare-associated sepsis and infections is expected to increase the demand for disposable surgical devices in the forecast years. Various studies have suggested that reductions in surgical site infections and the need for corrective surgery have been associated with the adoption of disposable devices and instruments.
Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using a variety of strategies. To gain market share, companies are expanding the range of products being offered. Industry participants use a variety of growth strategies such as collaborations, mergers and acquisitions, product launches, and the development of new goods to bolster their positions in the market.
In June 2023, Arterex acquired NextPhase Medical Devices from Kidd & Company. Arterex is a medical device contract manufacturer while NextPhase Medical Devices is a subsidiary of Kidd & Company, a family office investment firm. NextPhase is a contract manufacturer of class II and III medical devices including complex electromechanical devices, active implantable devices, and single-use surgical disposables in North America. The acquisition increased the size of the organization by two-fold, creating a top-tier global medical device contract manufacturer with 70% of its revenues generated in the United States.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.